Bangstad syndrome
disease diseaseOn this page
Also known as ataxia-diabetes-goiter-gonadal insufficiency syndromeBird-headed dwarfism with progressive ataxia, insulin-resistant diabetes, goiter and primary gonadal insufficiencyBird-headed dwarfism with progressive ataxia, insulin-resistant diabetes, goitre and primary gonadal insufficiency
Summary
Bangstad syndrome (MONDO:0008874) is a disease. A subtype of polyendocrinopathy — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
- Phenotypes (HPO): 21
Clinical features
Epidemiology
Prevalence records
2 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Cases/families | 2 | Worldwide | Validated | |
| Point prevalence | <1 / 1 000 000 | Worldwide | Validated |
Signs & symptoms
Clinical features (HPO)
21 HPO clinical features (Orphanet curated; top 21 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0000035 | Abnormal testis morphology | Very frequent (80-99%) |
| HP:0000147 | Polycystic ovaries | Very frequent (80-99%) |
| HP:0000164 | Abnormality of the dentition | Very frequent (80-99%) |
| HP:0000252 | Microcephaly | Very frequent (80-99%) |
| HP:0000275 | Narrow face | Very frequent (80-99%) |
| HP:0000340 | Sloping forehead | Very frequent (80-99%) |
| HP:0000444 | Convex nasal ridge | Very frequent (80-99%) |
| HP:0000490 | Deeply set eye | Very frequent (80-99%) |
| HP:0000821 | Hypothyroidism | Very frequent (80-99%) |
| HP:0000828 | Abnormality of the parathyroid gland | Very frequent (80-99%) |
| HP:0000842 | Hyperinsulinemia | Very frequent (80-99%) |
| HP:0001249 | Intellectual disability | Very frequent (80-99%) |
| HP:0001250 | Seizure | Very frequent (80-99%) |
| HP:0001251 | Ataxia | Very frequent (80-99%) |
| HP:0001511 | Intrauterine growth retardation | Very frequent (80-99%) |
| HP:0002353 | EEG abnormality | Very frequent (80-99%) |
| HP:0003118 | Increased circulating cortisol level | Very frequent (80-99%) |
| HP:0004097 | Deviation of finger | Very frequent (80-99%) |
| HP:0004322 | Short stature | Very frequent (80-99%) |
| HP:0008193 | Primary gonadal insufficiency | Very frequent (80-99%) |
| HP:0100651 | Type I diabetes mellitus | Very frequent (80-99%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | Bangstad syndrome |
| Mondo ID | MONDO:0008874 |
| MeSH | C537902 |
| OMIM | 210740 |
| Orphanet | 1227 |
| SNOMED CT | 237614004 |
| UMLS | C0342284 |
| MedGen | 90978 |
| GARD | 0000812 |
| Is cancer (heuristic) | no |
Also known as: ataxia-diabetes-goiter-gonadal insufficiency syndrome · Bangstad syndrome · Bird-headed dwarfism with progressive ataxia, insulin-resistant diabetes, goiter and primary gonadal insufficiency · Bird-headed dwarfism with progressive ataxia, insulin-resistant diabetes, goitre and primary gonadal insufficiency
Disease family
Classification path: disease › human disease › disease by body system or component › endocrine system disorder › polyendocrinopathy › Bangstad syndrome
Related subtypes (6): retinohepatoendocrinologic syndrome, immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome, autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome, multiple polyglandular tumor, neuroectodermal-endocrine syndrome, autoimmune polyendocrinopathy
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.